Matter of Cabrera

552 A.2d 1114, 381 Pa. Super. 100, 1989 Pa. Super. LEXIS 35
CourtSupreme Court of Pennsylvania
DecidedJanuary 13, 1989
Docket1799 and 2006
StatusPublished
Cited by11 cases

This text of 552 A.2d 1114 (Matter of Cabrera) is published on Counsel Stack Legal Research, covering Supreme Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Matter of Cabrera, 552 A.2d 1114, 381 Pa. Super. 100, 1989 Pa. Super. LEXIS 35 (Pa. 1989).

Opinion

POPOVICH, Judge:

This case involves cross-appeals from the order (later reduced to judgment) entered in this matter on the 6th day of June, 1988, adjudicating Tara Cabrera dependent and appointing a guardian ad litem to consent to her blood-transfusion-therapy for a period of one year. We affirm.

The facts, unlike the legal conclusions to be drawn therefrom, are not in dispute and reveal that Frank and Virginia Ingram, on the 18th day of February, 1988, transported their six-year-old daughter Tara to Children’s Hospital of Philadelphia for diagnosis and treatment for her fever, limp and pain in her hip.

Dr. Kwaku Ohene-Frempong, the Director of the Sickle Cell Program and Hematology at Children’s Hospital of *102 Philadelphia, was the attending physician for incoming patients diagnosed as having sickle-cell anemia. 1 After a series of neurological and orthopedic tests, a CAT scan revealed evidence of “an old stroke” in Tara’s brain. Her symptoms were diagnosed as the recurrence of her initial stroke.

In order to calculate the extent of damage sustained by Tara, Dr. Frempong recommended a blood transfusion to reduce the number of sickle-cells in her system. This would avail the doctor the opportunity to gauge more accurately the damage caused by the stroke(s), and, thus, prescribe a course of treatment.

The Ingrams refused, on both medical and religious grounds, to give consent to the transfusions. As a result, Children’s Hospital of Philadelphia filed a petition with Common Pleas Court seeking its appointment as special guardian to Tara to consent to a series of blood transfusions.

A hearing was held on March 2, 1988, in which Doctor Frempong testified that Tara’s condition was consistent with other children with sickle-cell anemia who have had strokes and are not transfused, i.e., 70% of them will have a recurrent stroke and 80% of those recurrences will take place within the first three years after the initial stroke. As a consequence thereof, Doctor Frempong noted the likelihood of increased risk of crippling and mental retardation. As for the risk of death in such cases, he stated: “The risk of death is smaller in children and much higher” in adults. The “only” treatment presently available for the illness, as observed by Doctor Frempong, was blood transfusions, which, it was stated, would prevent strokes from recurring in 90% of the cases.

*103 Albeit there are inherent risks in administering transfusions, 2 Doctor Frempong believed it “may be the best of two evils” in the treatment of sickle-cell patients. Once the tests were conducted, the doctor would have a better idea of the damage to the blood vessels in the brain, and what risks would be involved if transfusions were not ordered.

Mrs. Ingram appeared at the hearing and voiced her objections to the transfusions. Her religious ground was linked to her being a Jehovah’s Witness, a tenet which does not subscribe to the use of blood in any form on the individual. As for her medical objections, she pointed to the fact that Doctor Frempong would not assure (“guarantee”) her that Tara would not die immediately after the transfusions. Since she perceived her daughter to be in good health, she saw no need for the transfusions.

The court disagreed with Mrs. Ingram and permitted Children’s Hospital of Philadelphia to conduct the transfusions to assess Tara’s brain damage, if any. Then, once this was completed, it could be determined whether transfusions would be in order for four years or more to minimize a recurrence of another stroke.

At the follow-up hearing held on April 5, 1988, Doctor Frempong testified that the results of Tara’s arteriogram indicated that she had blood vessel damage to the right and left sides of her brain. This type of damage was consistent with “sickle cell children who have had strokes.” As for Tara, who clearly showed signs of “major” vessel disease, Doctor Frempong opined that the probability of recurrence of a stroke would be in the 70-80 percentile range. In *104 regard to the risks associated with the treatment to Tara in this case, the doctor stated:

We know for a fact this child has a very high risk for recurrent strokes and that with recurrence of strokes there is more brain damage, more potential for crippling brain damage and also mental retardation____[A]gainst all the risks, we still feel this is the best treatment available for children with sickle-cell disease who have had strokes. It is by no means the best one would have hoped for, but it is the only treatment available. (Emphasis added)

Before the court made its decision on whether to order additional transfusions, the parents of Tara were afforded the chance to secure opinions from other doctors as to alternative forms of treatment for this child. As a result thereof, a hearing was held on the 29th day of April, 1988, wherein Mrs. Ingram presented evidence from two doctors supposedly supportive of her contention that blood transfusions, and their inherent risks, were not the only means by which to minister to Tara’s condition.

The first physician was a Doctor Pourfar, a hematologist residing in New York City. Mrs. Ingram and Tara visited him, and he examined the patient and her hospital records. He recommended, in his two-page hand-written letter, that transfusions should be implemented only if Tara’s hemoglobin (Hb) level dropped below 7.5 grams. He noted that folic acid and aspirin should be continued to be administered to the patient.

The second doctor, one William H. Pogue, was a hematologist from New Britain, Connecticut, and he prepared a two-page typed report in which he made reference to alternative methods of treating Tara, e.g., aiitiplatelet agents (coumadin, aspirin and sulfinpyrazone). However, he conceded in his report that he could “find no evidence in the medical literature of any systematic study of alternative therapy.” In essence, it would appear that Doctor Pogue was espousing in his report the use of antiplatelet agents as an alternative therapeutic choice to blood transfusion thera *105 py. Even though none had been tested, he believed the risk involved was no more acute than the present therapy with blood transfusion, the efficacy of which no one could “guarantee” in preventing another stroke.

When Doctor Frempong took the stand, he commented that Doctor Pourfar’s recommendation that Tara might need a transfusion only if her hemoglobin dropped below 7.5 was “utter nonsense.”

Since the average blood count for most patients is between 6.0 and 9.0, at any one time, about 40% would have hemoglobin that low and still be healthy and without the need for any blood transfusion. Thus, remarked Doctor Frempong, Doctor Pourfar “is confused about the reason why we may be recommending transfusions for Tara.” As for Doctor Pogue’s report, Doctor Frempong noted that some of the alternative therapies mentioned came from a study done at Children’s Hospital of Philadelphia.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In the Interest of: C.B., Appeal of: I.Q.
Superior Court of Pennsylvania, 2026
Layton-Herron, M. v. Litke, K.
2026 Pa. Super. 15 (Superior Court of Pennsylvania, 2026)
Matter of Martin F.
2006 NY Slip Op 26339 (Monroe Family Court, 2006)
In re Martin F.
13 Misc. 3d 659 (NYC Family Court, 2006)
Jason S. v. Valley Hospital Medical Center
87 P.3d 521 (Nevada Supreme Court, 2004)
HCA, INC. v. Miller Ex Rel. Miller
36 S.W.3d 187 (Court of Appeals of Texas, 2000)
MN v. Southern Baptist Hosp. of Florida, Inc.
648 So. 2d 769 (District Court of Appeal of Florida, 1994)
Vest v. State Ex Rel. New Mexico Human Services Department
866 P.2d 1175 (New Mexico Court of Appeals, 1993)
Matter of Guardianship Petition of Lupe C.
812 P.2d 365 (New Mexico Court of Appeals, 1991)
Newmark v. Williams
588 A.2d 1108 (Supreme Court of Delaware, 1991)

Cite This Page — Counsel Stack

Bluebook (online)
552 A.2d 1114, 381 Pa. Super. 100, 1989 Pa. Super. LEXIS 35, Counsel Stack Legal Research, https://law.counselstack.com/opinion/matter-of-cabrera-pa-1989.